Amgen

Open: 314.5 Close: 324.56 Change: 10.06

Stop reading the whole internet to decide if you want to invest in Amgen.

The game is changing. There is a new strategy to evaluate Amgen fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, Sanofi, Court, Manufacturing, Inc, status, day, and the …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen (NASDAQ:AMGN) is in the Health Care sector and Biotechnology industry. Q1 earnings are confirmed for Thursday, April 25, 2024. ETC-1002 may not be as effective as the PCSK9 drugs.

Today's News

Amgen Singapore Manufacturing Specialist Manufacturing (Process Support) Amgen is one of the worlds leading independent biotechnology companies. Japan and Asia Pacific is the fastest growing region in Amgen. Amgen Inc. is an Equal Opportunity Employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status. Amgen will report its fourth quarter and full year 2023 financial results on February 6, 2024. The webcast will be available for replay for at least 90 days after the event. Amgen is committed to unlocking the potential of biology for patients. Amgen Inc. v. Sanofi is a United States Supreme Court case. Amgen sued Sanofi for infringing Amgens patents on antibodies that lower LDL cholesterol. The Court held that Amgen patents were invalid for lack of enablement. Amgen (amgn) stock moves -0.11%: what you should know - january 31, 2024 - zacks.com. amgen closed the most recent trading day. Ratings for Amgen (NASDAQ:AMGN) were provided by 11 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. Amgen will present at the 2024 J.P. Morgan Healthcare Conference. ETC-1002 may not be as effective as the PCSK9 drugs. Amgen (NASDAQ:AMGN) is in the Health Care sector and Biotechnology industry. Q1 earnings are confirmed for Thursday, April 25, 2024. Amgen will present at the 42nd Annual J.P. Morgan Healthcare Conference. Amgen has an excellent track record, but that is not enough to make it attractive to its attractive shares. Amgen v. Sanofi, the Supreme Court unanimously affirmed a federal Circuit decision holding invalid for lack of enablement. Amgen regional account manager - south west and south wales jobs at amgen in bristol. Your efforts will involve generate clinical demand, facilitate local access, and engage in formulary, pathway and funding initiatives. Maintenance Technician (Utilities) is maintenance technician. Amgen FleX Batch facility will combine the latest in disposable technologies with traditional stainless-steel equipment.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

This document will help you to evaluate Amgen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, Sanofi, Court, Manufacturing, Inc, status, day, and the most common words in the summary are: amgen, stock, market, top, amgn, price, research, . One of the sentences in the summary was: ETC-1002 may not be as effective as the PCSK9 drugs.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #stock #market #top #amgn #price #research.